Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand
Clinical trial NCT04429295 · COMPLETED
Trial details
- NCT number
- NCT04429295
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-28
- Primary completion
- 2021-02-26
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.